NewsBenzingaAvalyn Pharma informa que Respiratory Research publica resultados detallados de dos ensayos clínicos de fase 1 de AP02 en voluntarios sanos y pacientes con FPI, validando el enfoque antifibrótico inhalado Avalyn Pharma informa que Respiratory Research publica resultados detallados de dos ensayos clínicos de fase 1 de AP02 en voluntarios sanos y pacientes con FPI, validando el enfoque antifibrótico inhalado Benzinga 2026.09.21 13:04 (GMT+0) Open on Benzinga Other news StoneX Maintains Buy on Rivian Automotive, Lowers Price Target to $20 Amer Sports Unleashes $1 Billion Buyback, Raises 2026 Outlook EXCLUSIVE: Tesla Still Rules Leveraged ETFs, but Anthropic IPO and Micron’s Rise Signal What’s Next StoneX Reiterates Hold on iQIYIto Hold StoneX Maintains Buy on Baidu, Lowers Price Target to $125 Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide
Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide